Investor Presentation
Cautionary Statement Concerning Forward-Looking Statements. This document contains forward-looking statements. In addition, from time to time, we or our
representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events,
which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: expected future
revenue, integration of our recent acquisitions, expansion of our global footprint, expansion of our product offerings; our financial performance and projections; our growth in
revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that
use terminology such as "may," "should,” “expects,” “anticipates," "contemplates,” “estimates,” “believes,” “plans," "projected,” “predicts," "potential," or "hopes" or the negative of
these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability
to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ
materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements
made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions
about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking
events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
About non-IFRS financial measures to supplement our condensed consolidated financial statements, which are prepared and presented in accordance with International Financial
Reporting Standards ("IFRS"), we use the following non-IFRS financial measures: Adjusted EBITDA and Adjusted EBITDA margin. Adjusted EBITDA is a non-IFRS financial
measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. The Company
calculates adjusted EBITDA as total net loss, plus (minus) income taxes (recovery), plus (minus) interest expense (income), plus depreciation and amortization, plus (minus)
non-operating expense (income), plus share based compensation, plus impairment charges, plus (minus) fair value adjustments on investments, plus charges related to the
flow-through of inventory step-up on business combinations, plus other acquisition and transaction costs, plus (minus) non-cash fair value adjustments on the sale of inventory and
biological assets. Adjusted EBITDA margin % is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to
similar measures presented by other companies. The Company calculates adjusted EBITDA margin % as adjusted EBITDA, as described above, divided by revenue for the period.
FLORA GROWTH
2View entire presentation